JP Stock MarketDetailed Quotes

4506 Sumitomo Pharma

Watchlist

404
-3-0.74%

20min DelayMarket Closed Jul 5 15:00 JST

160.51BMarket Cap-509P/E (Static)

Sumitomo Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

Total revenue

-43.38%314.56B

-16.53%79.53B

-41.56%82.39B

-51.73%76.96B

-52.66%75.69B

-0.80%555.54B

-25.54%95.28B

1.90%140.98B

-1.92%159.41B

21.86%159.88B

Cost of revenue

-29.25%126.58B

-14.73%33.39B

-29.96%32.87B

-36.11%29.89B

-33.93%30.43B

13.87%178.92B

-0.35%39.15B

14.50%46.93B

21.91%46.79B

19.70%46.06B

Gross profit

-50.09%187.98B

-17.79%46.14B

-47.35%49.52B

-58.21%47.06B

-60.24%45.26B

-6.52%376.63B

-36.70%56.13B

-3.40%94.05B

-9.29%112.63B

22.76%113.82B

Operating expense

19.67%542.84B

145.61%283.26B

-2.59%80.77B

-47.49%81.99B

-2.40%96.82B

32.37%453.6B

33.07%115.33B

-4.37%82.91B

83.95%156.16B

17.52%99.21B

Selling and administrative expenses

15.06%429.54B

183.83%237.98B

-29.48%57.51B

-54.72%59.15B

-3.10%74.89B

49.88%373.32B

39.62%83.85B

26.73%81.56B

108.62%130.62B

24.54%77.29B

-General and administrative expense

15.06%429.54B

183.83%237.98B

-29.48%57.51B

-54.72%59.15B

-3.10%74.89B

49.88%373.32B

39.62%83.85B

26.73%81.56B

108.62%130.62B

24.54%77.29B

Research and development costs

-14.58%112.64B

-30.20%38.99B

-10.47%23.29B

-11.92%22.51B

14.01%27.84B

38.94%131.86B

105.97%55.86B

17.85%26.02B

9.80%25.56B

8.89%24.42B

Other operating expenses

382.33%8.13B

999.33%6.61B

51.72%663M

20.27%439M

49.47%423M

53.83%1.69B

171.95%601M

-1.35%437M

137.01%365M

1.80%283M

Total other operating income

-85.98%7.47B

-98.72%320M

-97.20%702M

-71.79%110M

127.22%6.34B

2,113.47%53.26B

3,326.89%24.98B

14,662.35%25.1B

-66.18%390M

687.57%2.79B

Operating profit

-360.98%-354.86B

-300.52%-237.11B

-380.54%-31.25B

19.75%-34.93B

-452.86%-51.57B

-227.80%-76.98B

-3,051.25%-59.2B

4.52%11.14B

-210.86%-43.53B

75.95%14.61B

Net non-operating interest income (expenses)

9.24%31.75B

111.12%19.19B

40.57%-17.82B

-45.10%9.86B

-35.88%20.52B

27.86%29.06B

-40.87%9.09B

-629.59%-29.98B

778.76%17.95B

9,267.91%32B

Non-operating interest income

11.81%36.02B

116.66%20.73B

----

-43.11%10.71B

-35.17%21.32B

24.99%32.22B

-40.68%9.57B

----

625.76%18.82B

5,281.18%32.88B

Non-operating interest expense

35.39%4.28B

221.46%1.54B

-40.57%17.82B

-1.73%851M

-9.40%800M

3.57%3.16B

-37.01%480M

3,753.47%29.98B

57.45%866M

-8.02%883M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

Other non-operating income (expenses)

Income before tax

-574.28%-323.11B

-334.87%-217.92B

-160.40%-49.06B

1.96%-25.08B

-166.62%-31.05B

-157.76%-47.92B

-388.36%-50.11B

-215.47%-18.84B

-161.91%-25.58B

485.77%46.61B

Income tax

-116.77%-8.19B

-248.07%-20.69B

161.66%899M

-78.61%3.8B

-57.83%7.81B

15.19%48.79B

16.84%13.98B

-113.11%-1.46B

46.41%17.76B

159.01%18.52B

Net income

-225.63%-314.93B

-207.75%-197.23B

-187.41%-49.96B

33.37%-28.87B

-238.34%-38.86B

-338.21%-96.71B

-1,283.07%-64.09B

-434.57%-17.38B

-248.51%-43.33B

3,380.92%28.09B

Net income continuous operations

-225.63%-314.93B

-207.75%-197.23B

-187.41%-49.96B

33.37%-28.87B

-238.34%-38.86B

-338.21%-96.71B

-1,283.07%-64.09B

-434.57%-17.38B

-248.51%-43.33B

3,380.92%28.09B

Noncontrolling interests

100.18%40M

100.38%31M

100.06%4M

100.04%2M

99.90%-3M

-40.40%-22.2B

-74.19%-8.08B

-30.81%-6.17B

-100.28%-4.94B

24.48%-3.02B

Net income attributable to the company

-322.71%-314.97B

-252.19%-197.26B

-345.38%-49.97B

24.78%-28.88B

-224.92%-38.86B

-232.08%-74.51B

-657.09%-56.01B

-213.22%-11.22B

-221.31%-38.39B

547.81%31.11B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-322.71%-314.97B

-252.19%-197.26B

-345.38%-49.97B

24.78%-28.88B

-224.94%-38.87B

-232.08%-74.51B

-657.09%-56.01B

-213.22%-11.22B

-221.31%-38.39B

547.81%31.11B

Gross dividend payment

Basic earnings per share

-322.71%-792.79

-252.18%-496.51

-345.36%-125.77

24.79%-72.68

-224.93%-97.82

-232.09%-187.55

-657.23%-140.98

-213.23%-28.24

-221.30%-96.63

547.64%78.3

Diluted earnings per share

-322.71%-792.79

-252.19%-496.5154

-345.36%-125.77

24.79%-72.68

-224.93%-97.82

-232.09%-187.55

-657.23%-140.98

-213.23%-28.24

-221.30%-96.63

547.64%78.3

Dividend per share

-25.00%21

-50.00%7

0.00%14

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022
Total revenue	-43.38%314.56B	-16.53%79.53B	-41.56%82.39B	-51.73%76.96B	-52.66%75.69B	-0.80%555.54B	-25.54%95.28B	1.90%140.98B	-1.92%159.41B	21.86%159.88B
Cost of revenue	-29.25%126.58B	-14.73%33.39B	-29.96%32.87B	-36.11%29.89B	-33.93%30.43B	13.87%178.92B	-0.35%39.15B	14.50%46.93B	21.91%46.79B	19.70%46.06B
Gross profit	-50.09%187.98B	-17.79%46.14B	-47.35%49.52B	-58.21%47.06B	-60.24%45.26B	-6.52%376.63B	-36.70%56.13B	-3.40%94.05B	-9.29%112.63B	22.76%113.82B
Operating expense	19.67%542.84B	145.61%283.26B	-2.59%80.77B	-47.49%81.99B	-2.40%96.82B	32.37%453.6B	33.07%115.33B	-4.37%82.91B	83.95%156.16B	17.52%99.21B
Selling and administrative expenses	15.06%429.54B	183.83%237.98B	-29.48%57.51B	-54.72%59.15B	-3.10%74.89B	49.88%373.32B	39.62%83.85B	26.73%81.56B	108.62%130.62B	24.54%77.29B
-General and administrative expense	15.06%429.54B	183.83%237.98B	-29.48%57.51B	-54.72%59.15B	-3.10%74.89B	49.88%373.32B	39.62%83.85B	26.73%81.56B	108.62%130.62B	24.54%77.29B
Research and development costs	-14.58%112.64B	-30.20%38.99B	-10.47%23.29B	-11.92%22.51B	14.01%27.84B	38.94%131.86B	105.97%55.86B	17.85%26.02B	9.80%25.56B	8.89%24.42B
Other operating expenses	382.33%8.13B	999.33%6.61B	51.72%663M	20.27%439M	49.47%423M	53.83%1.69B	171.95%601M	-1.35%437M	137.01%365M	1.80%283M
Total other operating income	-85.98%7.47B	-98.72%320M	-97.20%702M	-71.79%110M	127.22%6.34B	2,113.47%53.26B	3,326.89%24.98B	14,662.35%25.1B	-66.18%390M	687.57%2.79B
Operating profit	-360.98%-354.86B	-300.52%-237.11B	-380.54%-31.25B	19.75%-34.93B	-452.86%-51.57B	-227.80%-76.98B	-3,051.25%-59.2B	4.52%11.14B	-210.86%-43.53B	75.95%14.61B
Net non-operating interest income (expenses)	9.24%31.75B	111.12%19.19B	40.57%-17.82B	-45.10%9.86B	-35.88%20.52B	27.86%29.06B	-40.87%9.09B	-629.59%-29.98B	778.76%17.95B	9,267.91%32B
Non-operating interest income	11.81%36.02B	116.66%20.73B	----	-43.11%10.71B	-35.17%21.32B	24.99%32.22B	-40.68%9.57B	----	625.76%18.82B	5,281.18%32.88B
Non-operating interest expense	35.39%4.28B	221.46%1.54B	-40.57%17.82B	-1.73%851M	-9.40%800M	3.57%3.16B	-37.01%480M	3,753.47%29.98B	57.45%866M	-8.02%883M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
Income before tax	-574.28%-323.11B	-334.87%-217.92B	-160.40%-49.06B	1.96%-25.08B	-166.62%-31.05B	-157.76%-47.92B	-388.36%-50.11B	-215.47%-18.84B	-161.91%-25.58B	485.77%46.61B
Income tax	-116.77%-8.19B	-248.07%-20.69B	161.66%899M	-78.61%3.8B	-57.83%7.81B	15.19%48.79B	16.84%13.98B	-113.11%-1.46B	46.41%17.76B	159.01%18.52B
Net income	-225.63%-314.93B	-207.75%-197.23B	-187.41%-49.96B	33.37%-28.87B	-238.34%-38.86B	-338.21%-96.71B	-1,283.07%-64.09B	-434.57%-17.38B	-248.51%-43.33B	3,380.92%28.09B
Net income continuous operations	-225.63%-314.93B	-207.75%-197.23B	-187.41%-49.96B	33.37%-28.87B	-238.34%-38.86B	-338.21%-96.71B	-1,283.07%-64.09B	-434.57%-17.38B	-248.51%-43.33B	3,380.92%28.09B
Noncontrolling interests	100.18%40M	100.38%31M	100.06%4M	100.04%2M	99.90%-3M	-40.40%-22.2B	-74.19%-8.08B	-30.81%-6.17B	-100.28%-4.94B	24.48%-3.02B
Net income attributable to the company	-322.71%-314.97B	-252.19%-197.26B	-345.38%-49.97B	24.78%-28.88B	-224.92%-38.86B	-232.08%-74.51B	-657.09%-56.01B	-213.22%-11.22B	-221.31%-38.39B	547.81%31.11B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	6M	0	0	0	0	0
Net income attributable to common stockholders	-322.71%-314.97B	-252.19%-197.26B	-345.38%-49.97B	24.78%-28.88B	-224.94%-38.87B	-232.08%-74.51B	-657.09%-56.01B	-213.22%-11.22B	-221.31%-38.39B	547.81%31.11B
Gross dividend payment
Basic earnings per share	-322.71%-792.79	-252.18%-496.51	-345.36%-125.77	24.79%-72.68	-224.93%-97.82	-232.09%-187.55	-657.23%-140.98	-213.23%-28.24	-221.30%-96.63	547.64%78.3
Diluted earnings per share	-322.71%-792.79	-252.19%-496.5154	-345.36%-125.77	24.79%-72.68	-224.93%-97.82	-232.09%-187.55	-657.23%-140.98	-213.23%-28.24	-221.30%-96.63	547.64%78.3
Dividend per share	0	0	0	0	0	-25.00%21	-50.00%7	0	0.00%14	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall